| Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter R Kouzy, J Abi Jaoude, A Kraitem, MB El Alam, B Karam, E Adib, J Zarka, ... Cureus 12 (3), 2020 | 1029 | 2020 |
| Microbiome factors in HPV-driven carcinogenesis and cancers D Lin, R Kouzy, J Abi Jaoude, SS Noticewala, AY Delgado Medrano, ... PLos pathogens 16 (6), e1008524, 2020 | 56 | 2020 |
| Stereotactic versus conventional radiation therapy for patients with pancreatic cancer in the modern era J Abi Jaoude, CP Thunshelle, R Kouzy, ND Nguyen, D Lin, L Prakash, ... Advances in radiation oncology 6 (6), 100763, 2021 | 22 | 2021 |
| A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers MB El Alam, TT Sims, R Kouzy, GWG Biegert, JABI Jaoude, TV Karpinets, ... PloS one 16 (3), e0247905, 2021 | 22 | 2021 |
| Characteristics of the multiplicity of randomized clinical trials for coronavirus disease 2019 launched during the pandemic R Kouzy, J Abi Jaoude, CJG Garcia, MB El Alam, CM Taniguchi, ... JAMA Network Open 3 (7), e2015100-e2015100, 2020 | 21 | 2020 |
| Performance status restriction in phase III cancer clinical trials J Abi Jaoude, R Kouzy, W Mainwaring, TA Lin, AB Miller, A Jethanandani, ... Journal of the National Comprehensive Cancer Network 18 (10), 1322-1326, 2020 | 20 | 2020 |
| Cancer Research after COVID-19: Where Do We Go from Here? LE Colbert, R Kouzy, J Abi Jaoude, EB Ludmir, CM Taniguchi Cancer Cell, 2020 | 20 | 2020 |
| Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies J Abi Jaoude, R Kouzy, ND Nguyen, D Lin, SS Noticewala, EB Ludmir, ... Current Problems in Cancer 44 (6), 100607, 2020 | 17 | 2020 |
| The radiotherapy quality assurance gap among phase III cancer clinical trials KL Corrigan, S Kry, RM Howell, R Kouzy, J Abi Jaoude, RR Patel, ... Radiotherapy and Oncology 166, 51-57, 2022 | 15 | 2022 |
| Impact of fiducial marker placement before stereotactic body radiation therapy on clinical outcomes in patients with pancreatic cancer S Moningi, J Abi Jaoude, R Kouzy, D Lin, ND Nguyen, CJG Garcia, ... Advances in Radiation Oncology 6 (2), 100621, 2021 | 12 | 2021 |
| Exclusion of older adults in COVID-19 clinical trials J Abi Jaoude, R Kouzy, MB El Alam, V Subbiah, CM Taniguchi, EB Ludmir, ... Mayo Clinic Proceedings 95 (10), 2293, 2020 | 12 | 2020 |
| Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers LE Colbert, MB El, EJ Lynn, J Bronk, TV Karpinets, X Wu, BV Chapman, ... Cancer Immunology Research 10 (2), 259-271, 2022 | 11 | 2022 |
| Food and Drug Administration approvals in phase 3 cancer clinical trials J Abi Jaoude, R Kouzy, M Ghabach, R Patel, D Pasalic, E Ghossain, ... BMC cancer 21 (1), 695, 2021 | 10 | 2021 |
| Patient-reported GI outcomes in patients with anal cancer receiving modern chemoradiation R Kouzy, J Abi Jaoude, D Lin, MB El Alam, BD Minsky, EJ Koay, P Das, ... JCO oncology practice 16 (12), e1524-e1531, 2020 | 9 | 2020 |
| Association between prior malignancy exclusion criteria and age disparities in cancer clinical trials RR Patel, R Parisi, V Verma, R Kouzy, J Abi Jaoude, TA Lin, CD Fuller, ... Cancers 14 (4), 1048, 2022 | 7 | 2022 |
| Patient-reported outcome measures in pancreatic cancer receiving radiotherapy R Kouzy, J Abi Jaoude, D Lin, ND Nguyen, MB El Alam, EB Ludmir, ... Cancers 12 (9), 2487, 2020 | 6 | 2020 |
| Inclusion of premenopausal women in breast cancer clinical trials KL Corrigan, R Kouzy, J Abi Jaoude, RR Patel, RM Layman, SH Giordano, ... The Breast 66, 204-207, 2022 | 5 | 2022 |
| Microbiome dynamics during chemoradiation therapy for anal cancer D Lin, MB El Alam, J Abi Jaoude, R Kouzy, JL Phan, JH Elnaggar, ... International Journal of Radiation Oncology* Biology* Physics 113 (5), 974-984, 2022 | 5 | 2022 |
| Impact factor and citation metrics in phase III cancer trials J Abi Jaoude, R Kouzy, M Rooney, P Thompson, R Patel, MC Turner, ... Oncotarget 12 (18), 1780, 2021 | 5 | 2021 |
| Performance status restriction in phase III cancer clinical trials. R Kouzy, J Abi Jaoude, W Mainwaring, T Lin, AB Miller, A Jethanandani, ... Journal of Clinical Oncology 38 (15_suppl), 2059-2059, 2020 | 5 | 2020 |
Joseph Abi JaoudeDepartment of Radiation Oncology, Stanford UniversityVerified email at stanford.edu
